A curated, source-verified library of the strongest available research on harm reduction, treatment outcomes, overdose prevention, and the comparative effectiveness of voluntary versus coercive addictions care. Every entry links to a peer-reviewed journal, government report, university source, or major public-health agency.
Profiles of widely cited researchers and clinicians in addictions and public health.
Showing 10 of 10 entries
University of British Columbia, School of Population and Public Health
Infectious-disease physician and epidemiologist. Former Executive Medical Director of the BC Centre for Disease Control. Leading Canadian voice on safer supply.
BC Centre on Substance Use / UBC
Internationally cited addictions medicine physician-researcher; co-author of Canadian OUD treatment guidelines.
British Columbia Centre on Substance Use / UBC
Director of Research, BCCSU. One of the world's most published researchers on supervised consumption services and drug-policy outcomes.
Dalla Lana School of Public Health, University of Toronto
Leading Canadian researcher on harm reduction service delivery and best practices for needle and syringe programs.
Simon Fraser University
Health-services researcher and lead investigator of the Vancouver At Home/Chez Soi site; cited in housing-first and substance-use evaluations.
National Institute on Drug Abuse (US)
Director, NIDA. Pre-eminent international authority on the neuroscience of addiction and evidence-based treatment.
National Drug and Alcohol Research Centre, UNSW Sydney
Leads Global Burden of Disease work on illicit drug use; lead/senior author on multiple Lancet substance-use series.
Saskatchewan Medical Association & College of Physicians and Surgeons of Saskatchewan · Arnold P, Salte B
Unprecedented joint declaration by SMA and CPSS opposing the rollout of involuntary treatment under the Compassionate Intervention Act.
Physicians warn the Act lacks an evidence base, increases post-release overdose risk, and that no validated assessment tool exists to define the 'capacity' threshold.
Canadian Society of Addiction Medicine (CSAM-SMCA)
National addiction-medicine society's formal position on inpatient involuntary addiction treatment.
CSAM-SMCA concludes there is 'a lack of high-quality evidence to either support or refute' efficacy; if used at all, InvTx must be last-resort, brief, medically managed with full OAT access, and externally evaluated.
Addiction Technology Transfer Center Network (Central East ATTC)
SAMHSA-endorsed clinical training translating Recovery-Oriented Systems of Care principles into community-based, person-directed practice.
Curated and maintained by Voluntary Treatment First Saskatchewan. Every entry links to a peer-reviewed journal, government report, university, or major public-health agency. Spot a broken link or missing study? Let us know.
